Did any adverse reactions happen during this study?
- There were 4.5% of participants who took 24 mg of verinurad and 300 mg of allopurinol who had adverse events. This was 1 out of 22 participants.
- There were 16.7% of participants who took 40 mg of verinurad and 300 mg of allopurinol who had adverse events. This was 4 out of 24 participants.
- There were 8.7% of participants who took the placebo who had adverse events. This was 2 out of 23 participants.

None of the participants stopped taking study treatment due to adverse reactions.

What serious adverse reactions happened during this study?
None of the participants had serious adverse reactions in this study.
None of the participants died during this study.

What adverse reactions happened during this study?
The most common adverse reaction was headache.

Adverse reactions
24 mg of verinurad | 40 mg of verinurad | Placebo
and 300 mg of allopurinol | and 300 mg of allopurinol
Headache | 4.5% (1) | 12.5% (3) | 0.0% (0)
Feeling sick | 0.0% (0) | 0.0% (0) | 4.3% (1)
Feeling sleepy | 0.0% (0) | 4.2% (1) | 0.0% (0)
Unusual smelling urine | 0.0% (0) | 0.0% (0) | 4.3% (1)
Pain when urinating | 0.0% (0) | 4.2% (1) | 0.0% (0)